BioSpace News Archive

Lone Star Bio

Coya Therapeutics Announces Acceptance of Peer-Reviewed Manuscript in the Medical Journal: Frontiers in Neurology

Coya Therapeutics, Inc. announces the acceptance of a peer-reviewed manuscript.

June 3, 2024
·
10 min read
Biotech Beach

YourChoice Therapeutics Completes Phase 1a Clinical Study for First Hormone-Free Male Birth Control Pill

YourChoice Therapeutics, Inc., pioneering hormone-free family planning products, has completed its first-in-human clinical study for YCT-529, designed to be the first hormone-free birth control pill for men.

June 3, 2024
·
4 min read
Deals

CNS Pharmaceuticals Announces Reverse Stock Split - June 4, 2024

CNS Pharmaceuticals, Inc. today announced a 1-for-50 reverse split of its common stock, effective at 4:01 PM ET on June 4, 2024.

June 3, 2024
·
3 min read
Deals

electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules

electroCore, Inc. today announced that it has agreed to issue and sell to an institutional accredited investor an aggregate of 225,000 registered pre-funded warrants to purchase shares of common stock and unregistered warrants to purchase up to an aggregate of 112,500 shares of common stock.

June 3, 2024
·
6 min read
Business

Sengenics Corporation Announces New Collaboration to Advance Cancer Treatment

Sengenics Corporation LLC and Duke Health today announced an ambitious collaboration to redefine metastatic colorectal cancer (mCRC) treatment.

June 3, 2024
·
4 min read
Pharm Country

Celularity Presents Data of The Effect of Its T-Cell Platform on Multiple Hematological And Solid Tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting

Celularity Inc., a regenerative and cellular medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial products, announced that it presented in vivo data from its T-cell therapy platform at this year’s ASCO Annual Meeting in Chicago.

June 3, 2024
·
5 min read
Drug Development

TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0

TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of IFx-2.0.

June 3, 2024
·
15 min read
BioMidwest

Longeveron® Announces Contract Development and Manufacturing Business and First Contract

Longeveron Inc. announced the launch of its contract development and manufacturing business at the Company’s 15,000 square feet state-of-the-art Good Manufacturing Practice facility.

June 3, 2024
·
8 min read
BioMidwest

AIM ImmunoTech to Participate in the Virtual Investor Lunch Break Series

AIM ImmunoTech Inc., announced that Thomas K. Equels, MS JD, Chief Executive Officer of AIM will participate in the Virtual Investor Lunch Break Series on Wednesday, June 5, 2024 at 12:00 PM ET.

June 3, 2024
·
1 min read
Deals

Aeterna Zentaris and Ceapro Complete Merger Transaction

Aeterna Zentaris Inc. and Ceapro Inc. are pleased to announce the successful completion and closing of their all-stock merger of equals transaction, which was previously announced by Aeterna and Ceapro in their joint press release of December 14, 2023.

June 3, 2024
·
10 min read